SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-24-041733
Filing Date
2024-05-10
Accepted
2024-05-10 16:15:45
Documents
11

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0205085-f1_neurosense.htm F-1 446071
2 OPINION OF GOLDFARB GROSS SELIGMAN & CO., ISRAELI COUNSEL TO THE REGISTRANT ea020508501ex5-1_neuro.htm EX-5.1 11660
3 OPINION OF GREENBERG TRAURIG, P.A., U.S. COUNSEL TO THE REGISTRANT ea020508501ex5-2_neuro.htm EX-5.2 15476
4 CONSENT OF SOMEKH CHAIKIN (MEMBER FIRM OF KPMG INTERNATIONAL), INDEPENDENT REGIS ea020508501ex23-1_neuro.htm EX-23.1 1948
5 FILING FEE TABLE ea020508501ex-fee_neuro.htm EX-FILING FEES 26422
6 GRAPHIC image_001.jpg GRAPHIC 12873
7 GRAPHIC image_002.jpg GRAPHIC 14883
8 GRAPHIC ex5-1_001.jpg GRAPHIC 11779
9 GRAPHIC ex5-1_002.jpg GRAPHIC 12702
10 GRAPHIC ex5-1_003.jpg GRAPHIC 13697
11 GRAPHIC ex5-2_001.jpg GRAPHIC 2827
  Complete submission text file 0001213900-24-041733.txt   598140
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-279324 | Film No.: 24935070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)